[HTML][HTML] Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology

MI Fonseca, SO McGuire, SE Counts… - Journal of …, 2013 - Springer
Background Alzheimer's disease (AD) is a neurodegenerative dementia characterized by
the decline of cognition and the presence of neuropathological changes including neuronal …

Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease

MI Fonseca, RR Ager, SH Chu, O Yazan… - The Journal of …, 2009 - journals.aai.org
Alzheimer's disease (AD) is an age-related dementia, characterized by amyloid plaques,
neurofibrillary tangles, neuroinflammation, and neuronal loss in the brain. Components of …

Microglial C5aR (CD88) expression correlates with amyloid‐β deposition in murine models of Alzheimer's disease

RR Ager, MI Fonseca, SH Chu… - Journal of …, 2010 - Wiley Online Library
J. Neurochem.(2010) 113, 389–401. Abstract Alzheimer's disease (AD), a progressive
neurodegenerative disease characterized by the accumulation of amyloid‐β protein and …

[HTML][HTML] C5aR1 antagonism alters microglial polarization and mitigates disease progression in a mouse model of Alzheimer's disease

A Gomez-Arboledas, K Carvalho… - Acta neuropathologica …, 2022 - Springer
Multiple studies have recognized the involvement of the complement cascade during
Alzheimer's disease pathogenesis. However, the specific role of C5a-C5aR1 signaling in the …

The role of complement anaphylatoxin C5a in neurodegeneration: implications in Alzheimer's disease

P Mukherjee, GM Pasinetti - Journal of neuroimmunology, 2000 - Elsevier
There is evidence that the complement system, a major component of inflammatory
responses, may play an important role in neurodegenerative conditions such as Alzheimer's …

Complement C5a receptor-mediated signaling may be involved in neurodegeneration in Alzheimer's disease

I Farkas, M Takahashi, A Fukuda… - The Journal of …, 2003 - journals.aai.org
In our earlier results, we demonstrated that cells expressing the complement C5aR are
vulnerable since abnormal activation of C5aR caused apoptosis of these cells. In this study …

[HTML][HTML] Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease

C Landlinger, L Oberleitner, P Gruber, B Noiges… - Journal of …, 2015 - Springer
Background Alzheimer's disease (AD) is the most common neurodegenerative disease
characterized by neuronal loss due to amyloid beta aggregations, neurofibrillary tangles …

The C5a complement activation peptide increases IL-1β and IL-6 release from amyloid-β primed human monocytes: implications for Alzheimer's disease

S O'Barr, NR Cooper - Journal of neuroimmunology, 2000 - Elsevier
Alzheimer's disease (AD) brains contain large numbers of amyloid-β peptide (Aβ) deposits
associated with activated microglia, astrocytes and dystrophic neurites. Activated …

Gamma subunit of complement component 8 is a neuroinflammation inhibitor

JH Kim, R Afridi, J Han, HG Jung, SC Kim, EM Hwang… - Brain, 2021 - academic.oup.com
The complement system is part of the innate immune system that comprises several small
proteins activated by sequential cleavages. The majority of these complement components …

Complement protein C5a enhances the β-amyloid-induced neuro-inflammatory response in microglia in Alzheimer's disease

X An, W Xi, C Gu, X Huang - médecine/sciences, 2018 - medecinesciences.org
Objective: The dysregulation of neuro-inflammation is one of the attributes of the
pathogenesis of Alzheimer's disease (AD). Over-expression of complement proteins co …